Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 23;12(3):896.
doi: 10.3390/jcm12030896.

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

Giuseppe De Luca  1   2 Stephane Manzo-Silberman  3 Magdy Algowhary  4 Berat Uguz  5 Dinaldo C Oliveira  6 Vladimir Ganyukov  7 Oliver Busljetik  8 Miha Cercek  9 Lisette Okkels  10 Poay Huan Loh  11 Lucian Calmac  12 Gerard Roura I Ferrer  13 Alexandre Quadros  14 Marek Milewski  15 Fortunato Scotto di Uccio  16 Clemens von Birgelen  17 Francesco Versaci  18 Jurrien Ten Berg  19 Gianni Casella  20 Aaron Wong Sung Lung  21 Petr Kala  22 José Luis Díez Gil  23 Xavier Carrillo  24 Maurits Dirksen  25 Victor Becerra  26 Michael Kang-Yin Lee  27 Dafsah Arifa Juzar  28 Rodrigo de Moura Joaquim  29 Roberto Paladino  30 Davor Milicic  31 Periklis Davlouros  32 Nikola Bakraceski  33 Filippo Zilio  34 Luca Donazzan  35 Adriaan Kraaijeveld  36 Gennaro Galasso  37 Lux Arpad  38 Lucia Marinucci  39 Vincenzo Guiducci  40 Maurizio Menichelli  41 Alessandra Scoccia  42 Aylin Hatice Yamac  43 Kadir Ugur Mert  44 Xacobe Flores Rios  45 Tomas Kovarnik  46 Michal Kidawa  47 Josè Moreu  48 Vincent Flavien  49 Enrico Fabris  50 Iñigo Lozano Martínez-Luengas  51 Marco Boccalatte  52 Francisco Bosa Ojeda  53 Carlos Arellano-Serrano  54 Gianluca Caiazzo  55 Giuseppe Cirrincione  56 Hsien-Li Kao  57 Juan Sanchis Forés  58 Luigi Vignali  59 Helder Pereira  60 Santiago Ordoñez  61 Alev Arat Özkan  62 Bruno Scheller  63 Heidi Lehtola  64 Rui Teles  65 Christos Mantis  66 Ylitalo Antti  67 João António Brum Silveira  68 Cesar Rodrigo Zoni  69 Ivan Bessonov  70 Giuseppe Uccello  71 George Kochiadakis  72 Dimitrios Alexopulos  73 Carlos E Uribe  74 John Kanakakis  75 Benjamin Faurie  76 Gabriele Gabrielli  77 Alejandro Gutierrez Barrios  78 Juan Pablo Bachini  79 Alex Rocha  80 Frankie C C Tam  81 Alfredo Rodriguez  82 Antonia Anna Lukito  83 Veauthyelau Saint-Joy  84 Gustavo Pessah  85 Andrea Tuccillo  16 Alfonso Ielasi  2 Giuliana Cortese  86 Guido Parodi  87 Mohamed Abed Bouraghda  88 Marcia Moura  14 Elvin Kedhi  89 Pablo Lamelas  61 Harry Suryapranata  90 Matteo Nardin  91 Monica Verdoia  92
Affiliations

Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

Giuseppe De Luca et al. J Clin Med. .

Abstract

Background: Several reports have demonstrated the impact of the COVID-19 pandemic on the management and outcome of patients with ST-segment elevation myocardial infarction (STEMI). The aim of the current analysis is to investigate the potential gender difference in the effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI patients within the ISACS-STEMI COVID-19 Registry.

Methods: This retrospective multicenter registry was performed in high-volume primary percutaneous coronary intervention (PPCI) centers on four continents and included STEMI patients undergoing PPCIs in March-June 2019 and 2020. Patients were divided according to gender. The main outcomes were the incidence and timing of the PPCI, (ischemia time ≥ 12 h and door-to-balloon ≥ 30 min) and in-hospital or 30-day mortality.

Results: We included 16683 STEMI patients undergoing PPCIs in 109 centers. In 2020 during the pandemic, there was a significant reduction in PPCIs compared to 2019 (IRR 0.843 (95% CI: 0.825-0.861, p < 0.0001). We did not find a significant gender difference in the effects of the COVID-19 pandemic on the numbers of STEMI patients, which were similarly reduced from 2019 to 2020 in both groups, or in the mortality rates. Compared to prepandemia, 30-day mortality was significantly higher during the pandemic period among female (12.1% vs. 8.7%; adjusted HR [95% CI] = 1.66 [1.31-2.11], p < 0.001) but not male patients (5.8% vs. 6.7%; adjusted HR [95% CI] = 1.14 [0.96-1.34], p = 0.12).

Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures similarly observed in both genders. Furthermore, we observed significantly increased in-hospital and 30-day mortality rates during the pandemic only among females. Trial registration number: NCT 04412655.

Keywords: COVID-19; ST-segment elevation myocardial infarction; gender; percutaneous coronary intervention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest concerning the submitted study.

Figures

Figure 2
Figure 2
Bar graphs on the left side show the association between the year of intervention and time delays (ischemia times longer than 12 h in left upper graph; door-to-balloon times longer than 30 min in left lower graph). Bar Graphs on the right side show the association between the year of intervention with in-hospital (right upper graph) and 30-day mortality (right lower graph) rates.
Figure 1
Figure 1
Box-and-whisker plot (on the left) showing the numbers of STEMI patients treated by mechanical reperfusion per million inhabitants/year in 2019 and 2020. The right graph shows the incidence rate ratio with 95% confidence intervals across each center.
Figure 3
Figure 3
Kaplan–Meier survival curves of STEMI patients treated in 2019 and 2020.

References

    1. Axenhus M., Schedin-Weiss S., Winblad B., Wimo A. Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden. Scand. J. Public Health. 2021;50:748–755. doi: 10.1177/14034948211064656. - DOI - PMC - PubMed
    1. Coronavirus (COVID-19) Deaths. [(accessed on 31 January 2022)]. Available online: https://ourworldindata.org/covid-deaths.
    1. Garcia S., Albaghdadi M.S., Meraj P.M., Schmidt C., Garberich R., Jaffer F.A., Dixon S., Rade J.J., Tannenbaum M., Chambers J., et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic. J. Am. Coll. Cardiol. 2020;75:2871–2872. doi: 10.1016/j.jacc.2020.04.011. - DOI - PMC - PubMed
    1. Tam C.F., Cheung K.S., Lam S., Wong A., Yung A., Sze M., Lam Y.M., Chan C., Tsang T.C., Tsui M., et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ. Cardiovasc Qual. Outcomes. 2020;13:e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. - DOI - PMC - PubMed
    1. Piccolo R., Bruzzese D., Mauro C., Aloia A., Baldi C., Boccalatte M., Bottiglieri G., Briguori C., Caiazzo G., Calabrò P., et al. Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19. Outbreak Circ. 2020;141:2035–2037. doi: 10.1161/CIRCULATIONAHA.120.047457. - DOI - PMC - PubMed